girentuximab
heidelberg pharmaceuticals,,esteve,prometheus
['renal,(-adrenal)', 'zircon', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'girentuximab', 'imab ']
results from phase 3 study of 89zr-dfo-girentuximab for pet/ct imaging of clear cell renal cell carcinoma (zircon). #gu23 
Medical Oncologist - Urologic Oncology. Hospital Universitario La Paz - IdiPAZ, Madrid